Nuzenio

Tradingview Aort

Tradingview Aort entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

ARTIVION, INC. 2026: Revenue $125.76M, EPS ($0.28) — 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 18:01:01 GMTArtivion Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 12:24:32 GMTAORT: Q2 revenue and EBITDA grew strongly, with AMDS PMA approval and NEXUS acquisition fueling outlook - TradingViewTradingView · Thu, 06 Aug 2026 22:01:04 GMTAORT: Q2 2026 saw strong revenue, EBITDA growth, FDA approvals, and acquisitions driven by On-X and stent grafts - TradingViewTradingView · Thu, 06 Aug 2026 20:23:29 GMTAORT: Q2 2026 revenue rose 11% year-over-year, with Endospan acquired and AMDS FDA-approved - TradingViewTradingView · Thu, 06 Aug 2026 20:14:16 GMTAORT Q2'26 Earnings: EPS estimate is 0.00 USD - TradingViewTradingView · Wed, 05 Aug 2026 11:01:14 GMTAORT: Double-digit growth driven by innovative aortic products, strong clinical data, and expanding markets - TradingViewTradingView · Sat, 01 Aug 2026 20:27:33 GMT

Timeline

Fri, 07 Aug 2026 18:01:01 GMTARTIVION, INC. 2026: Revenue $125.76M, EPS ($0.28) — 10-Q Summary - TradingView
Fri, 07 Aug 2026 12:24:32 GMTArtivion Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 22:01:04 GMTAORT: Q2 revenue and EBITDA grew strongly, with AMDS PMA approval and NEXUS acquisition fueling outlook - TradingView
Thu, 06 Aug 2026 20:23:29 GMTAORT: Q2 2026 saw strong revenue, EBITDA growth, FDA approvals, and acquisitions driven by On-X and stent grafts - TradingView
Thu, 06 Aug 2026 20:14:16 GMTAORT: Q2 2026 revenue rose 11% year-over-year, with Endospan acquired and AMDS FDA-approved - TradingView
Wed, 05 Aug 2026 11:01:14 GMTAORT Q2'26 Earnings: EPS estimate is 0.00 USD - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Aort.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.